Previous experimental murine studies have shown that activation of the transcription factor nuclear factor kappa B (NF-κB) plays an important role as an early and central event in the pathogenesis of AP [7,23,24], which could represent the potential therapeutic target. Here, NFKB1 is linked to alkaline phosphatase measurement.